Cholecalciferol (vitaminD3)

DRUG2 trials

Sponsors

Heba Omara, King Faisal Specialist Hospital & Research Center

Conditions

Corona Virus Disease 19 (COVID-19)Cystic Fibrosis and Non CF Bronchiectasis

Phase 1

The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients

CompletedNCT07068282

King Faisal Specialist Hospital & Research CenterCorona Virus Disease 19 (COVID-19)

Start: 2024-07-24End: 2025-02-12Updated: 2025-07-16

Phase 2

The Role of Vitamin D3 in Pediatric Bronchiectasis Severity

CompletedNCT04411901

Heba OmaraCystic Fibrosis and Non CF Bronchiectasis

Start: 2018-03-01End: 2019-03-20Updated: 2020-06-02

Related Papers

Vitamin D3 oral rinsing reduces salivary SARS-CoV-2 antigen detectability: a clinical trial with public health implications

Frontiers in Oral Health2026-09-01